Postmenopausal clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
- BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
- Hydration & Female Life Stages
- Observation of Environment and Reproductive-Endocrine Effects
- Prebiotics (Dried Plum) and Immune Function in Postmenopausal Women
- GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
- Protein and Exercise for Postmenopausal Women's Wellbeing
- Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women
- Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women
- Oral Antioxidant Therapy Targeted to the Mitochondria for Improving Brain Artery Health in Postmenopausal Women
- Dairy Choline Bioavailability
- Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Postmenopausal” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.